搜索替代词:
remove. » remote. (扩展搜索)
removed. » remoted. (扩展搜索)
resolved. » resulted. (扩展搜索)
Showing 281 - 300 results of 1,860 for search 'form is (((((remove. OR evolveddsssdss.) OR resolved.) OR involves.) OR involved.) OR removed.)', 查询时间: 0.15s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288

    Benign bone tumor fixation case with pathologic reviews. Jeong Eun Moon (21594026)

    出版 2025
    “...<p>A: This one-year postoperative photograph of a patient, who underwent curettage, pure β-TCP (Neobone<sup>®</sup>) grafting, and 2-hole compressive hip screw fixation for left femur subtrochanteric nonossifying fibroma, demonstrates the healing of the benign bone tumor. B: Implant removal was performed simultaneously with scar revision, and the area around the Lag screw hole was curettaged and filled with a 13 mm cylindrical pure β-TCP (Neobone<sup>®</sup>) bone substitute graft. ...”
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293

    Selected genes characterized by heterogeneous expression of spliced and unspliced forms. Daniil K. Lukyanov (20997755)

    出版 2025
    “...<i>FOS</i>—encoding a c-Fos protein which interacts with c-Jun, forming heterodimeric AP-1 transcription factor that prominently affects CD4<sup>+</sup> T cell differentiation [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013682#pcbi.1013682.ref080" target="_blank">80</a>]. ...”
  14. 294

    Selected genes characterized by heterogeneous expression of spliced and unspliced forms. Daniil K. Lukyanov (20997755)

    出版 2025
    “...<i>FOS</i>—encoding a c-Fos protein which interacts with c-Jun, forming heterodimeric AP-1 transcription factor that prominently affects CD4<sup>+</sup> T cell differentiation [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013682#pcbi.1013682.ref080" target="_blank">80</a>]. ...”
  15. 295

    Stable Isotope Labeling of Pyrimidines Using a Deconstruction–Reconstruction Strategy Benjamin J. H. Uhlenbruck (22267064)

    出版 2025
    “...By deconstructing pyrimidines into vinamidinium salts and reconstructing them with deuterium, <sup>13</sup>C, and <sup>15</sup>N-enriched amidines, we achieve high isotopic enrichment across various substitution patterns, including complex drug-like pyrimidine derivatives. The process involves a Tf<sub>2</sub>O-mediated ring-opening and ring-closing sequence to form a pyrimidinium ion, followed by cleavage to the vinamidinium salt with pyrrolidine. ...”
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300